Often, clinical trial results do not end up being disclosed. How can companies address this lack of transparency in clinical research? Darshan Kulkarni investigates the four ways in which health care companies can improve data transparency while...
Patient centricity has become a major focal point for companies in 2019. What are four ways life science companies can incorporate patient centricity? Join Darshan Kulkarni as he discusses how health care companies can implement more patient-centric...
Promotional Review Committees (PRCs) serve an important role for pharmaceutical companies wanting to stay compliant. How can PRCs help ensure compliance for promotional materials? In this episode, Darshan talks about how companies should handle LESE...
Promotional Review Committees (PRCs) serve an important role for pharmaceutical companies. How can PRCs help ensure compliance for promotional materials? Join Darshan Kulkarni as he talks about how your company should review its promotional...
How will Pharmacogenomics look in 2020? Is your company sufficiently prepared? Join FDA regulatory attorney Darshan Kulkarni as he discusses how pharmacogenomics may change in 2020, and whether your clinical trials may be affected.
How might patient centricity progress in 2020, and what does this mean for your company? In this episode, Darshan Kulkarni talks about the different factors affecting clinical trial transparency, and the four branches of patient centricity. We'll...